Judith Graham - Kaiser Health News

Far more older adults who perished with COVID lived outside of institutions. People with dementia and other severe neurological conditions, chronic kidney disease and immune deficiencies were hit hard.

The FDA approves new prescribing instructions for Aduhelm to address confusion over who should get the drug, saying it is appropriate for patients with early or mild Alzheimer’s.

Between 2 million and 4.4 million older adults are homebound and at extremely high risk of dying from COVID-19. Yet, they haven’t been recognized as a priority group for vaccines.

Long-term care residents’ participation in the vaccination effort is clouded by a significant complication: More than half have cognitive impairment or dementia.